Turkey herpesvirus vectored recombinant containing avian influenza genes

Inactive Publication Date: 2008-10-02
ZEON CORP +1
View PDF1 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0028]The present avian bivalent vaccine is able to confer serological titer by HI of more than 50 (geometric mean titer) in groups of vaccinated chickens

Problems solved by technology

These differences are probably due to the genetically unstabl

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Turkey herpesvirus vectored recombinant containing avian influenza genes
  • Turkey herpesvirus vectored recombinant containing avian influenza genes
  • Turkey herpesvirus vectored recombinant containing avian influenza genes

Examples

Experimental program
Comparison scheme
Effect test

example 1

Hemagglutinin Gene Isolation from Avian Influenza Virus H5 Subtype

[0039]The avian influenza virus A / Turkey / Wisconsin / 68 (H5N9) strain was propagated in the allantoic sac of specific pathogen free embryonating chicken eggs. Total genomic RNA from the A / Turkey / Wisconsin / 68 virus was extracted using RNEASY MINI KIT (QIAGEN, Cat# 74104). First-strand cDNA was synthesized with SUPERSCRIPT FIRST-STRAND System for RT-PCR (Invitrogen, Cat# 11904-018). Using the resulting cDNA as a template, the HA gene was amplified by polymerase chain reaction (PCR) with PFUULTRA HIGH FIDELITY DNA Polymerase (STRATAGENE, Cat# 600380) and PCR primers. These PCR primers, BamHA-F primer (SEQ ID NO: 4) and SalHA-R primer (SEQ ID NO: 5), anneal to the start and stop sequences of the HA gene and each primer contains a sequence at the 5′ ends for a restriction enzyme, BamHI or SalI, respectively. After the PCR reaction, Taq polymerase (PROMEGA, Cat# M2665) was added to the PCR mixture to add 3′ A-overhangs to the...

example 2

Construction of Homology Plasmids

2-1. A Summary of Homology Plasmids and Recombinant Turkey Herpesviruses

[0042]In the present invention, three promoters, the CMV promoter, the chicken beta-actin promoter (Bac promoter), and a modified chicken beta-actin promoter (Pec promoter), were used to control expression of the HA gene of the AI virus A / Turkey / Wisconsin / 68 (H5N9) strain. First, homology plasmids with the HA gene and one of the promoters were constructed and then recombinant turkey herpesviruses were generated using the homology plasmids. The recombinant turkey herpesviruses with different promoters were compared for capabilities of conferring serological titers against AI in chickens as shown in EXAMPLE 6. A recombinant HVT with the CMV promoter is presented here as an example and recombinant viruses with the Bac promoter or the Pec promoter are presented here as comparative examples. A list of the homology plasmids and the recombinant turkey herpesviruses constructed in the pr...

example 3

Generation and Isolation of Recombinant Turkey Herpesvirus

[0048]Viral DNA of the HVT FC126 strain was prepared as described by Morgan et al. (Avian Diseases, 1990, 34:345-351).

[0049]107 secondary chicken embryo fibroblast (CEF) cells were suspended in Saline G (0.14 M NaCl, 0.5 mM KCl, 1.1 mM Na2HPO4, 1.5 mM NaH2PO4, 0.5 mM MgCl2, and 0.011% glucose) and co-transfected with HVT viral DNA and 5 to 25 μg of the homology plasmid, p45CMVH5Wis68, p45BaCH5Wis68, or p45PeCH5Wis68 by electroporation. Electroporation was performed using BIO-RAD GENE PULSER. Transfected cells were incubated for 10 minutes at room temperature and transferred to wells of 96-well plates. After incubating at 37° C. for 7 days in 4-5% CO2, or until the plaques became visible, the cells were detached from the plates by trypsinization, transferred equally to two 96-well plates with secondary CEF and incubated for 3 to 4 days until plaques were observed. Screening was conducted by the black plaque assay, staining onl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.

Description

CROSS-REFERENCES TO RELATED APPLICATIONS[0001]Not applicable.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]Not applicable.THE NAMES OF PARTIES TO A JOINT RESEARCH AGREEMENT[0003]The following are parties to a joint research agreement effective Jun. 15, 2005: Biomune Company (a Kansas general partnership), Zeon Corporation (Japan) and Ceva Sante Animale S. A. (France).REFERENCE TO SEQUENCE LISTING[0004]The Sequence Listing in the file named “070161 Sequence Listing” on the one concurrently submitted Compact Disk is hereby incorporated by reference.BACKGROUND OF THE INVENTION[0005]1. Field of the Invention[0006]The present invention relates generally to avian vaccines against avian influenza (AI). More specifically, the present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin (HA) protein of avian influenza virus under a promoter.[0007]2. Description of the Related Art[0008]Avian influenza is cau...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/00A61P43/00C12N1/21
CPCA61K39/145A61K2039/5256C12N15/86C12N2710/16443C12N2760/16134C07K14/11C12N2710/16343C12N15/63C12N2710/16143C12N7/00C12N15/85C12N2830/60C12N2830/34C12N15/869A61K39/12A61P31/16A61P31/22A61P43/00C07K14/005C12N2710/16334
Inventor ESAKI, MOTOYUKIJENSEN, LAUREN ELIZABETHDORSEY, KRISTI M.
Owner ZEON CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap